The effect of infliximab on precentage of body fat and weight in psoriasis patients
Not Applicable
- Conditions
- psoriasis.psoriasis
- Registration Number
- IRCT2013082912065N1
- Lead Sponsor
- Tehran University of Medical Science,Razi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
inclusion criteria :
patients with psoriasis; candidate for treatment with infliximab; having consent from the patient to participate in the study; no contradiction for infliximab treatment
exclusion criteria :
not being able to follow up the patient; pregnant women; breastfeeding women; concomitant use of other cytotoxic drugs; Severe complications leading to treatment discontinuation; concomitant use of systemic retinoid
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body mass index. Timepoint: before initiation of the study,week 6,12, and 24 after the last dose. Method of measurement: weight with kilograms on a scale,height with meters with the use of a rubber meter.;Lean body mass. Timepoint: before initiation of the study,week 6,12, and 24 after the last dose. Method of measurement: weight with kilograms on a scale,height with meters with the use of a rubber meter.
- Secondary Outcome Measures
Name Time Method eptin. Timepoint: before initiation and after the last dose. Method of measurement: lab.;Cholestrol. Timepoint: before initiation and after the last dose. Method of measurement: lab.;Trigliseride. Timepoint: before initiation and after the last dose. Method of measurement: lab.